Topic

New Jersey

A collection of 536 issues

The Requirements Checklist to Get Rystiggo (rozanolixizumab-noli) Covered by Cigna in New Jersey

Answer Box: Getting Rystiggo (rozanolixizumab-noli) Covered by Cigna in New Jersey Cigna requires prior authorization for Rystiggo (rozanolixizumab-noli) in New Jersey. You need confirmed AChR or MuSK antibody-positive generalized myasthenia gravis, MGFA Class II-IV symptoms, and documentation of inadequate response to standard therapies. Submit electronically via CoverMyMeds for fastest processing.
6 min read

How to Get Sylvant (Siltuximab) Covered by Aetna CVS Health in New Jersey: Complete PA Guide & Appeals Process

Answer Box: Getting Sylvant (Siltuximab) Covered by Aetna CVS Health in New Jersey Aetna CVS Health requires prior authorization for Sylvant (siltuximab) for idiopathic multicentric Castleman disease (iMCD), with approval typically taking 14-30 days. Submit via CVS Specialty's Oncology Injectable form with HIV-negative/HHV-8-negative lab results, pathology confirming
5 min read

How to Get Epidiolex (Cannabidiol) Covered by UnitedHealthcare in New Jersey: Complete Approval Guide with Forms and Timelines

Answer Box: Getting Epidiolex Covered by UnitedHealthcare in New Jersey Epidiolex (cannabidiol) requires prior authorization from UnitedHealthcare for FDA-approved seizure disorders (Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex). Most plans require documentation of at least two failed antiepileptic drugs and specialist involvement. If denied, New Jersey offers external review
5 min read

How to Get Abecma (idecabtagene vicleucel) Covered by UnitedHealthcare in New Jersey: Complete Guide with Appeals Process and Alternative Options

Answer Box: Getting Abecma Covered by UnitedHealthcare in New Jersey Fastest path to approval: Submit prior authorization through UnitedHealthcare's medical benefit (not pharmacy) with complete documentation of relapsed/refractory multiple myeloma after ≥2 prior lines including an IMiD, proteasome inhibitor, and anti-CD38 antibody. If denied, file internal appeal
6 min read